
Newsletters
An update of Viapath's world of pathology
'Welcome to the fifteenth edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'
'Welcome to the fourteenth edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'
'Welcome to the thirteenth edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'
'Welcome to the eleventh edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'
'Welcome to the Tenth edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'
'Welcome to the Ninth edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'
'Welcome to the Eight edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'
'Welcome to the seventh edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'
'Welcome to the sixth edition of pathology@viapath, updating you with what's happenong at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining'
Inside This Issue
- Cervical Cancer screening in England - The journey so far
- New Assays: For Pregabalin, Gabapentin and Methylphenidate in urine
- How genetic and molecular innovation in pathology will improve NHS outcomes for patients
- Why urine steroid profiling is still the gold standard for identification of steroid-related disorders
- Viapath Career Development Programme
- Genetic analysis of samples from miscarriages usins a new efficient molecular testing strategy
'Welcome to the fifth edition of pathology@viapath, updating you with what's happening at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining.'
'Welcome to the fourth edition of “pathology@viapath”, an update on a selection of interesting projects and work being performed by Viapath‟s scientists as well as some of the fun events that have taken place.'
'Welcome to the second edition of pathology@viapath, updating you with information from Viapath's scientists, the tests that are being run and the research that is being undertaken.'
Inside This Issue:
- Case Study: Vitamin B12 Deficiency
- Hepatitis E Virus: An Emerging Zoonosis
- Improving the Diagnosis of Invasive Fungal Infections in Critically Ill Patients
- Why and How Should Vitamin D2 and D3 be Measued?
- World Thrombosis Day 2016
- Why and How Should Vitamin B12 be Measure?
'Welcome to the first edition of pathology@viapath, updating you with what's happening at Viapath. Hopefully you'll find the contents useful, informative and maybe even entertaining.'
Inside This Issue:
- Context and Applications of Targeted Genetic Testing
- Zika Virus: News and Views
- Listen to Pathology Podcasts from Viapath's Future Leaders in Innovation Group
- Urgent Urine Porphobilinogen (PBG) Service Introduced
- Modernising Urine Drugs of Abuse Testing
Share this page
- Tweet
Last updated: 26/01/2017